The ALECENSA Staying Positive Text Program is an ALECENSA Support Program offering helpful information about ALECENSA, additional resources, and practical tips on an array of topics about living with ALK+ mNSCLC delivered via SMS/text message.
The Staying Positive Text Program includes:
More information is available here: https://www.alecensa.com/patient/patient-support/register.html
For purposes of these Terms, “Genentech,” “we,” or “us” shall mean Genentech, Inc. and any of its applicable partners, affiliates, subcontractors, and agents.
YOU AGREE TO RESOLVE DISPUTES WITH GENENTECH THROUGH BINDING ARBITRATION, AND YOU WAIVE ANY RIGHT TO PARTICIPATE IN CLASS ACTIONS, ALL AS DETAILED IN OUR TERMS & CONDITIONS, WHICH ARE INCORPORATED INTO THESE TERMS. YOU MAY OPT OUT OF THE BINDING INDIVIDUAL ARBITRATION AND CLASS ACTION WAIVER AS PROVIDED THEREIN.
Opting in to Receive SMS/Text Messages
By opting in to the Program, you expressly consent to receive recurring marketing text messages that may be sent using an automatic telephone dialing system, by or on behalf of Genentech, at the mobile number you provide to us or use when signing up via short code. Please note that we may not be able to deliver messages to all mobile carriers.
Your consent to the Program is voluntary and is not required as a condition of any purchase. The frequency of the messages may vary and, if the Program includes messages that are scheduled for specific intervals, you may receive a separate notification regarding when you will receive the messages.
The Program may include sending/receiving the messages through cellular telephone operators, mobile carriers, and other networks (“mobile provider”). We do not charge for the Program, but text messages are subject to your mobile provider’s terms of service and you are responsible for all charges and fees associated with text messaging imposed by your mobile provider. Message and data rates may apply. If you have any questions about your text plan or data plan, please contact your mobile provider.
Eligibility and Change in Phone Number
You must be a resident of the United States and 18 years of age or older to participate in the Program. By providing the mobile number that you provided when you signed up for the Program, you confirm that you are (a) a resident of the United States; (b) 18 years of age or older; and (c) the subscriber to that mobile number or that you are the customary user of that number and are authorized to opt in to and receive messages on it. You agree to immediately notify Genentech if the mobile number you provided changes.
To request more information, at any time you can text the keyword HELP, either in reply to a message or by texting it to the phone number or short code for the Program. For all questions regarding the Program, you may contact Genentech at (877) GENENTECH (877-436-3683).
How to Opt Out
To cancel the Program, you can text the keyword STOP, either in reply to a message or by texting it to the phone number or short code for the Program (ie, the number from which Program text messages are being sent). After you send the message “STOP” to us, we will send you a one-time opt out reply message to confirm that you have been unsubscribed. If you want to join again, just reply with the keyword START to our confirmation message to resubscribe. You may also opt out by contacting Genentech at (877) GENENTECH (877-436-3683).
If you unsubscribe from the Program, you may continue to receive text messages from Genentech through any other programs you have joined until you separately cancel those programs.
No Guarantee; Limitation of Liability
Genentech does not guarantee the successful delivery of text messages pursuant to the Program. Messages may not be delivered if the mobile phone number is not in range of a transmission site, or if sufficient network capacity is not available at a particular time. Even within a coverage area, factors beyond the control of wireless carriers may interfere with message delivery, including the customer's equipment, terrain, and proximity to buildings, foliage, and weather. Genentech will not be liable for losses or damages arising from (a) non-delivery, delayed delivery, or misdirected delivery of a text message; (b) inaccurate or incomplete content in a text message; or (c) use or reliance on the contents of any text message for any purposes.
UNDER NO CIRCUMSTANCES WILL GENENTECH BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES ARISING OUT OF, OR IN CONNECTION WITH, USE OF THE PROGRAM, WHETHER OR NOT GENENTECH HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
You agree to indemnify, defend, and hold Genentech harmless from any third-party claims, liability, damages, or costs arising from your use of the Program or from you providing us with a phone number that is not your own.
If you are dissatisfied with the Program or these Terms, your sole and exclusive remedy is to cancel the Program, as set forth above. Individuals who participate in the Program do so at their own risk.
Changes to SMS Terms
Genentech may revise, modify, or amend these Terms at any time. Any such revision, modification, or amendment shall take effect when it is posted online. You agree to review these Terms periodically to ensure that you are aware of any changes. Your continued consent to receive Program text messages will indicate your acceptance of those changes.
Termination of Text Messaging
Genentech may suspend or terminate your use of the Program if we believe you are in breach of these Terms. Your use of the Program is also subject to termination in the event that your mobile telephone service terminates or lapses. Genentech reserves the right to modify or discontinue, temporarily or permanently, all or any part of the Program, with or without notice.
Not Medical Advice
You understand that Program communications are not intended to be a replacement or substitute for professional medical advice. You acknowledge and understand that you will seek the advice of a physician or other qualified healthcare provider with any questions that arise regarding any medical condition.
Side Effect Reporting
You further understand that the Program involves automated messages and is not a means to communicate product issues or negative side effects. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
ALECENSA is a prescription medicine used to treat people with non-small cell lung cancer that has spread to other parts of the body (mNSCLC) and is caused by an abnormal anaplastic lymphoma kinase (ALK) gene. Your healthcare provider will perform a test to make sure that ALECENSA is right for you.
It is not known if ALECENSA is safe and effective in children.
Everyone reacts differently to treatment with ALECENSA. It’s important to know the most serious and most common side effects with ALECENSA.
Your doctor may lower the dose or stop treatment with ALECENSA if any side effects occur. Contact your doctor right away if you have any of the following side effects.
ALECENSA may cause serious side effects, including:
Liver problems (hepatotoxicity). ALECENSA may cause liver injury. Your doctor will do blood tests at least every 2 weeks for the first 3 months, and then 1 time each month and as needed during treatment with ALECENSA. Tell your doctor right away if you get any of the following signs and symptoms:
Lung problems. ALECENSA may cause severe or life-threatening swelling (inflammation) of the lungs during treatment. Symptoms may be similar to those symptoms from lung cancer. Tell your doctor right away if you have any new or worsening symptoms, including:
Kidney problems. ALECENSA may cause severe or life-threatening kidney problems. Tell your doctor right away if you have a change in the amount or color of your urine, or if you get new or worsening swelling in your legs or feet.
Slow heartbeat (bradycardia). ALECENSA may cause very slow heartbeats that can be severe. Your doctor will check your heart rate and blood pressure during treatment with ALECENSA. Tell your doctor right away if you feel dizzy, lightheaded, or if you faint during treatment with ALECENSA. Tell your doctor if you take any heart or blood pressure medicines.
Muscle pain, tenderness, and weakness (myalgia). Muscle problems are common with ALECENSA and can be severe. Your doctor will do blood tests at least every 2 weeks for the first month and as needed during treatment with ALECENSA. Tell your doctor right away if you have any new or worsening signs and symptoms of muscle problems, including unexplained muscle pain or muscle pain that does not go away, tenderness, or weakness.
Breakdown of healthy red blood cells earlier than normal (hemolytic anemia). Hemolytic anemia can happen in some people who take ALECENSA. If this happens, you may not have enough healthy red blood cells. Your doctor may temporarily stop ALECENSA and do blood tests, if needed, to check for this problem. If you develop hemolytic anemia, your doctor may either restart you on ALECENSA at a lower dose when the hemolytic anemia goes away, or may stop your treatment with ALECENSA. Tell your doctor right away if you experience yellow skin (jaundice), weakness or dizziness, or shortness of breath.
Before you take ALECENSA, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.
Avoid spending time in the sunlight during treatment with ALECENSA and for 7 days after the final dose of ALECENSA. You may burn more easily and get severe sunburns. Use sunscreen and lip balm with SPF 50 or greater to help protect against sunburn.
The most common side effects of ALECENSA include:
These are not all of the possible side effects of ALECENSA. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
Please see additional Important Safety Information in full Prescribing Information, including Patient Information.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.